Skip to main content
. 2023 Nov 29;11(3):2305217. doi: 10.1002/advs.202305217

Figure 6.

Figure 6

Long‐term immune response of combination therapy in orthotopic 4T1 tumor model. A) Schematic illustration of memory study. B) Tumor growth curve for combination therapy in 4T1 breast tumor model (n = 6). C) Representative photographs and HE staining of the lungs at the end of treatment. D) Quantitative analysis of metastatic nodules on the lungs (n = 5). E) Representative flow cytometry chart and F) percentage of central memory T cells (TCM) and effective memory T cells (TEM) in splenocytes after treatment (n = 4). G) Treatment schedule in 4T1 postsurgical tumor model. H) Tumor growth curves of the mice after surgical resection and various treatments (n = 10). I) Percent survival of mice after various treatments (n = 10). J) Individual tumor growth kineties after various treatments (n = 10). K) Summary of survival time of mice after various treatments. L) Representative photographs and M) quantitative analysis of metastatic nodules on the lungs (n = 10). Statistical data are presented as means ± SD. *P < 0.05, **P < 0.01.